BALYASNY ASSET MANAGEMENT L.P. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$80,585
+41.4%
90,954
+152.0%
0.00%
Q3 2022$57,000
-54.0%
36,094
-41.3%
0.00%
Q2 2022$124,000
+93.8%
61,446
+345.1%
0.00%
Q4 2021$64,000
-49.2%
13,805
-9.6%
0.00%
-100.0%
Q1 2021$126,000
-12.5%
15,266
-27.8%
0.00%0.0%
Q4 2020$144,000
-68.3%
21,130
-79.5%
0.00%
-50.0%
Q3 2018$454,000103,2520.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders